ATP13A2 and Parkinson disease: Relying on recent developments in the field, the development of a rat model with conditional Atp13a2 depletion (i.e., homozygous Atp13a2-floxed KO rats) induced soon after birth or in adulthood might be interesting in the study of KRS and PD, with the aim and hope of inducing dopaminergic neurodegeneration, enabling a better replication of the symptoms observed in patients.